Q32 Bio Inc. Quarterly Share-based Payment Arrangement, Expense in USD from Q1 2017 to Q2 2024

Taxonomy & unit
us-gaap: USD
Description
Amount of expense for award under share-based payment arrangement. Excludes amount capitalized.
Summary
Q32 Bio Inc. quarterly/annual Share-based Payment Arrangement, Expense history and growth rate from Q1 2017 to Q2 2024.
  • Q32 Bio Inc. Share-based Payment Arrangement, Expense for the quarter ending June 30, 2024 was $1.34M, a 331% increase year-over-year.
  • Q32 Bio Inc. Share-based Payment Arrangement, Expense for the twelve months ending June 30, 2024 was $8.47M, a 31% increase year-over-year.
  • Q32 Bio Inc. annual Share-based Payment Arrangement, Expense for 2023 was $7.32M, a 43.9% decline from 2022.
  • Q32 Bio Inc. annual Share-based Payment Arrangement, Expense for 2022 was $13.1M, a 24.3% decline from 2021.
  • Q32 Bio Inc. annual Share-based Payment Arrangement, Expense for 2021 was $17.2M, a 30.2% increase from 2020.
Share-based Payment Arrangement, Expense, Trailing 12 Months (USD)
Share-based Payment Arrangement, Expense, Quarterly (USD)
Share-based Payment Arrangement, Expense, YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q2 2024 $8.47M $1.34M +$1.03M +331% Apr 1, 2024 Jun 30, 2024 10-Q 2024-08-08
Q1 2024 $7.45M $417K +$121K +40.9% Jan 1, 2024 Mar 31, 2024 10-Q 2024-05-09
Q4 2023 $7.32M $5.01M +$1.92M +62.2% Oct 1, 2023 Dec 31, 2023 10-K 2024-03-13
Q3 2023 $5.4M $1.71M -$1.06M -38.4% Jul 1, 2023 Sep 30, 2023 10-Q 2023-11-14
Q2 2023 $6.47M $310K -$2.83M -90.1% Apr 1, 2023 Jun 30, 2023 10-Q 2024-08-08
Q1 2023 $9.3M $296K -$3.76M -92.7% Jan 1, 2023 Mar 31, 2023 10-Q 2024-05-09
Q4 2022 $13.1M $3.09M -$1.57M -33.8% Oct 1, 2022 Dec 31, 2022 10-K 2024-03-13
Q3 2022 $14.6M $2.77M -$1.46M -34.4% Jul 1, 2022 Sep 30, 2022 10-Q 2023-11-14
Q2 2022 $16.1M $3.14M -$1.33M -29.7% Apr 1, 2022 Jun 30, 2022 10-Q 2023-08-14
Q1 2022 $17.4M $4.05M +$168K +4.33% Jan 1, 2022 Mar 31, 2022 10-Q 2023-05-11
Q4 2021 $17.2M $4.66M +$1.1M +30.7% Oct 1, 2021 Dec 31, 2021 10-K 2023-03-09
Q3 2021 $16.1M $4.23M +$880K +26.3% Jul 1, 2021 Sep 30, 2021 10-Q 2022-11-10
Q2 2021 $15.3M $4.47M +$1.02M +29.6% Apr 1, 2021 Jun 30, 2021 10-Q 2022-08-15
Q1 2021 $14.2M $3.88M +$1M +34.7% Jan 1, 2021 Mar 31, 2021 10-Q 2022-05-16
Q4 2020 $13.2M $3.57M +$1.13M +46.4% Oct 1, 2020 Dec 31, 2020 10-K 2022-03-23
Q3 2020 $12.1M $3.35M +$1.36M +68.4% Jul 1, 2020 Sep 30, 2020 10-Q 2021-11-15
Q2 2020 $10.8M $3.45M +$1.48M +75.3% Apr 1, 2020 Jun 30, 2020 10-Q 2021-08-12
Q1 2020 $9.28M $2.88M +$1.64M +132% Jan 1, 2020 Mar 31, 2020 10-Q 2021-05-06
Q4 2019 $7.64M $2.44M +$1.48M +155% Oct 1, 2019 Dec 31, 2019 10-K 2021-03-11
Q3 2019 $6.15M $1.99M +$1.27M +176% Jul 1, 2019 Sep 30, 2019 10-Q 2020-11-09
Q2 2019 $4.89M $1.97M +$1.4M +246% Apr 1, 2019 Jun 30, 2019 10-Q 2020-08-10
Q1 2019 $3.49M $1.24M +$863K +227% Jan 1, 2019 Mar 31, 2019 10-Q 2020-05-07
Q4 2018 $2.62M $955K +$815K +583% Oct 1, 2018 Dec 31, 2018 10-K 2020-03-12
Q3 2018 $1.81M $719K +$661K +1142% Jul 1, 2018 Sep 30, 2018 10-Q 2019-11-12
Q2 2018 $1.15M $569K +$538K +1761% Apr 1, 2018 Jun 30, 2018 10-Q 2019-08-08
Q1 2018 $608K $380K +$352K +1273% Jan 1, 2018 Mar 31, 2018 10-Q 2019-05-13
Q4 2017 $256K $140K Oct 1, 2017 Dec 31, 2017 10-K 2019-03-12
Q3 2017 $57.9K Jul 1, 2017 Sep 30, 2017 10-Q 2018-11-13
Q2 2017 $30.6K Apr 1, 2017 Jun 30, 2017 10-Q 2018-08-13
Q1 2017 $27.7K Jan 1, 2017 Mar 31, 2017 10-Q 2018-05-14
* An asterisk sign (*) next to the value indicates that the value is likely invalid.